- Company Overview for QUANTUM PHARMACEUTICAL LIMITED (05240304)
- Filing history for QUANTUM PHARMACEUTICAL LIMITED (05240304)
- People for QUANTUM PHARMACEUTICAL LIMITED (05240304)
- Charges for QUANTUM PHARMACEUTICAL LIMITED (05240304)
- More for QUANTUM PHARMACEUTICAL LIMITED (05240304)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 15 Dec 2025 | CH01 | Director's details changed for Mr Stephen Peter Duncan on 5 December 2025 | |
| 15 Dec 2025 | CH01 | Director's details changed for Mr Stephen Peter Duncan on 5 December 2025 | |
| 30 Sep 2025 | CS01 | Confirmation statement made on 24 September 2025 with no updates | |
| 26 Sep 2025 | AA | Full accounts made up to 31 December 2024 | |
| 25 Feb 2025 | TM01 | Termination of appointment of Gillian Margaret Grant as a director on 24 February 2025 | |
| 06 Nov 2024 | CH01 | Director's details changed for Mr Lewis Campbell on 6 November 2024 | |
| 24 Sep 2024 | CS01 | Confirmation statement made on 24 September 2024 with no updates | |
| 05 Jul 2024 | AA | Full accounts made up to 31 December 2023 | |
| 20 Feb 2024 | RP04CS01 | Second filing of Confirmation Statement dated 24 September 2022 | |
| 05 Feb 2024 | PSC05 | Change of details for Target Healthcare Group Limited as a person with significant control on 6 July 2022 | |
| 26 Sep 2023 | CS01 | Confirmation statement made on 24 September 2023 with no updates | |
| 09 Jun 2023 | AA | Full accounts made up to 31 December 2022 | |
| 28 Sep 2022 | AA | Full accounts made up to 31 December 2021 | |
| 26 Sep 2022 | CS01 |
Confirmation statement made on 24 September 2022 with no updates
|
|
| 15 Sep 2022 | AP01 | Appointment of Mrs Gillian Grant as a director on 23 August 2022 | |
| 22 Aug 2022 | PSC02 | Notification of Target Healthcare Group Limited as a person with significant control on 6 July 2022 | |
| 22 Aug 2022 | PSC07 | Cessation of Target Healthcare Limited as a person with significant control on 6 July 2022 | |
| 30 May 2022 | TM01 | Termination of appointment of David Alan Sanson as a director on 30 May 2022 | |
| 21 Feb 2022 | MR04 | Satisfaction of charge 052403040015 in full | |
| 21 Feb 2022 | MR04 | Satisfaction of charge 052403040014 in full | |
| 21 Feb 2022 | MR04 | Satisfaction of charge 052403040013 in full | |
| 11 Feb 2022 | MR01 | Registration of charge 052403040016, created on 3 February 2022 | |
| 25 Oct 2021 | CS01 | Confirmation statement made on 24 September 2021 with updates | |
| 22 Jul 2021 | AA01 | Current accounting period extended from 30 June 2021 to 31 December 2021 | |
| 14 Jul 2021 | SH08 | Change of share class name or designation |